Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03114501 · ClinicalTrials.gov registry record · NA

Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers

A NA study of Head and Neck Cancer and Malignant Neoplasms of Lip Oral Cavity and Pharynx, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
236
Enrollment target
1
Study location

NCT03114501: Active NA study of Head and Neck Cancer and Malignant Neoplasms of Lip Oral Cavity and Pharynx, sponsored by M.D. Anderson Cancer Center.

NCT03114501 is a NA study of Head and Neck Cancer and Malignant Neoplasms of Lip Oral Cavity and Pharynx that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 236 participants, roughly in line with the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03114501, a NA study of Head and Neck Cancer and Malignant Neoplasms of Lip Oral Cavity and Pharynx, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
236 participants
Enrollment target
1
Study location

Study Summary

Objectives: Primary Aim: Examine the feasibility of a dyadic yoga program in 40 Head and Neck Cancer (HNC) patients undergoing radiotherapy (RT) and their family caregivers. Secondary Aims: 1\. Establish the initial efficacy of the yoga program in patients and their caregivers regarding quality of life (QOL) outcomes (i.e., fatigue, sleep disturbance, depressive symptoms, and overall QOL) and objective performance outcomes (i.e, sit to stand test and grip strength).

Primary Outcome

Trial considered feasible if 1) ≥ 50% of eligible couples consent (i.e., approach 80 couples to obtain 40 consents); 2) ≥ 70% of enrolled couples complete both assessments; 3) on average ≥ 50% of all practice sessions are attended.

Interventions

  • BEHAVIORAL Yoga
  • BEHAVIORAL Yoga Questionnaire
  • BEHAVIORAL Symptom Questionnaires

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 2017-04-11
Est. Completion 2027-04-30
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT03114501 still lists

NCT03114501 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target.

The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 3 interventions - of which Yoga is the first listed.

NCT03114501 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03114501 about?

NCT03114501 is a clinical study titled "Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers". Objectives: Primary Aim: Examine the feasibility of a dyadic yoga program in 40 Head and Neck Cancer (HNC) patients undergoing radiotherapy (RT) and their family caregivers. Secondary Aims: 1\. Establish the initial efficacy of the yoga program in patients and their caregivers regarding quality ...

What is the current status of trial NCT03114501?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 236 participants. The study started on 2017-04-11. Estimated completion is 2027-04-30.

What conditions does trial NCT03114501 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Malignant Neoplasms of Lip Oral Cavity and Pharynx.

What interventions are being tested in trial NCT03114501?

The interventions under investigation include: Yoga (BEHAVIORAL), Yoga Questionnaire (BEHAVIORAL), Symptom Questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT03114501?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03114501 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03114501's enrollment target sits among peer trials

236 46th of 250 higher than 205 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04995341 · 236 participants · NA

    Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)

  • NCT05822362 · 236 participants · Phase 2

    CBD for Individuals at Risk for Alzheimer's Disease

  • NCT06200103 · 236 participants · Phase 2

    Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

  • NCT06494072 · 236 participants · Phase 4

    Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03114501, the US trial registry maintained by the National Library of Medicine. NCT03114501 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.